• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 Jun 23;27(9).
doi: 10.3201/eid2709.211159. Online ahead of print.
Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland

Maureen Lynch, Guerrino Macori, Séamus Fanning, Edel O'Regan, Eoin Hunt, Dermot O'Callaghan, Brian McCullagh, Cormac Jennings, Anne Fortune

Abstract

We examined virus genomic evolution in an immunocompromised patient with prolonged severe acute respiratory syndrome coronavirus 2 infection. Genomic sequencing revealed genetic variation during infection: 3 intrahost mutations and possible superinfection with a second strain of the virus. Prolonged infection in immunocompromised patients may lead to emergence of new virus variants.

Keywords: 2019 novel coronavirus disease; B-cell therapy; COVID-19; SARS-CoV-2; coronavirus disease; immunocompromised; respiratory infections; severe acute respiratory syndrome coronavirus 2; superinfection; virus evolution; viruses; zoonoses.
 
Back
Top Bottom